130 related articles for article (PubMed ID: 26429314)
1. Repressing PU.1 by miR-29a∗ in NK cells of HCV patients, diminishes its cytolytic effect on HCV infected cell models.
Elemam NM; Mekky RY; El-Ekiaby NM; El Sobky SA; El Din MA; Esmat G; Abdelaziz AI
Hum Immunol; 2015 Sep; 76(9):687-94. PubMed ID: 26429314
[TBL] [Abstract][Full Text] [Related]
2. Contradicting roles of miR-182 in both NK cells and their host target hepatocytes in HCV.
El Sobky SA; El-Ekiaby NM; Mekky RY; Elemam NM; Mohey Eldin MA; El-Sayed M; Esmat G; Abdelaziz AI
Immunol Lett; 2016 Jan; 169():52-60. PubMed ID: 26518141
[TBL] [Abstract][Full Text] [Related]
3. Unraveling the expression of microRNA-27a* & NKG2D in peripheral blood mononuclear cells and natural killer cells of pediatric systemic lupus erythematosus patients.
Sourour SK; Aboelenein HR; Elemam NM; Abdelhamid AK; Salah S; Abdelaziz AI
Int J Rheum Dis; 2017 Sep; 20(9):1237-1246. PubMed ID: 28523761
[TBL] [Abstract][Full Text] [Related]
4. Enhancing NK cell cytotoxicity by miR-182 in hepatocellular carcinoma.
Abdelrahman MM; Fawzy IO; Bassiouni AA; Gomaa AI; Esmat G; Waked I; Abdelaziz AI
Hum Immunol; 2016 Aug; 77(8):667-673. PubMed ID: 27262453
[TBL] [Abstract][Full Text] [Related]
5. HBsAg stimulates NKG2D receptor expression on natural killer cells and inhibits hepatitis C virus replication.
Wang XX; Pan XB; Han JC; Cong X; Jin Q; Kong XS; Wei L; Feng B
Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):233-240. PubMed ID: 29625837
[TBL] [Abstract][Full Text] [Related]
6. Immunological changes in different patient populations with chronic hepatitis C virus infection.
Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
[TBL] [Abstract][Full Text] [Related]
7. Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.
Krämer B; Körner C; Kebschull M; Glässner A; Eisenhardt M; Nischalke HD; Alexander M; Sauerbruch T; Spengler U; Nattermann J
Hepatology; 2012 Oct; 56(4):1201-13. PubMed ID: 22532190
[TBL] [Abstract][Full Text] [Related]
8. Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells.
Yoon JC; Lim JB; Park JH; Lee JM
J Virol; 2011 Dec; 85(23):12557-69. PubMed ID: 21937646
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines.
Sène D; Levasseur F; Abel M; Lambert M; Camous X; Hernandez C; Pène V; Rosenberg AR; Jouvin-Marche E; Marche PN; Cacoub P; Caillat-Zucman S
PLoS Pathog; 2010 Nov; 6(11):e1001184. PubMed ID: 21085608
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-30c promotes natural killer cell cytotoxicity via up-regulating the expression level of NKG2D.
Ma Y; Gong J; Liu Y; Guo W; Jin B; Wang X; Chen L
Life Sci; 2016 Apr; 151():174-181. PubMed ID: 26968781
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus-infected cells downregulate NKp30 and inhibit ex vivo NK cell functions.
Holder KA; Stapleton SN; Gallant ME; Russell RS; Grant MD
J Immunol; 2013 Sep; 191(6):3308-18. PubMed ID: 23960237
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia impairs anti-viral activity of natural killer (NK) cells but has little effect on anti-fibrotic NK cell functions in hepatitis C virus infection.
Wolter F; Glässner A; Krämer B; Kokordelis P; Finnemann C; Kaczmarek DJ; Goeser F; Lutz P; Nischalke HD; Strassburg CP; Spengler U; Nattermann J
J Hepatol; 2015 Dec; 63(6):1334-44. PubMed ID: 26297916
[TBL] [Abstract][Full Text] [Related]
13. IDO1 impairs NK cell cytotoxicity by decreasing NKG2D/NKG2DLs via promoting miR-18a.
Zhang J; Han X; Hu X; Jin F; Gao Z; Yin L; Qin J; Yin F; Li C; Wang Y
Mol Immunol; 2018 Nov; 103():144-155. PubMed ID: 30268986
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-150 regulates the cytotoxicity of natural killers by targeting perforin-1.
Kim N; Kim M; Yun S; Doh J; Greenberg PD; Kim TD; Choi I
J Allergy Clin Immunol; 2014 Jul; 134(1):195-203. PubMed ID: 24698324
[TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell models.
Mekky RY; El-Ekiaby N; El Sobky SA; Elemam NM; Youness RA; El-Sayed M; Hamza MT; Esmat G; Abdelaziz AI
Arch Virol; 2019 Jun; 164(6):1587-1595. PubMed ID: 30949812
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus impairs natural killer cell-mediated augmentation of complement synthesis.
Kim H; Bose SK; Meyer K; Ray R
J Virol; 2014 Mar; 88(5):2564-71. PubMed ID: 24352446
[TBL] [Abstract][Full Text] [Related]
17. MiR-506 Promotes Natural Killer Cell Cytotoxicity against Human Hepatocellular Carcinoma Cells by Targeting STAT3.
Su Z; Ye X; Shang L
Yonsei Med J; 2019 Jan; 60(1):22-29. PubMed ID: 30554487
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D.
Heinemann A; Zhao F; Pechlivanis S; Eberle J; Steinle A; Diederichs S; Schadendorf D; Paschen A
Cancer Res; 2012 Jan; 72(2):460-71. PubMed ID: 22102694
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity.
Oliviero B; Mantovani S; Varchetta S; Mele D; Grossi G; Ludovisi S; Nuti E; Rossello A; Mondelli MU
J Hepatol; 2017 Jun; 66(6):1130-1137. PubMed ID: 28192188
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1.
Goh CC; Roggerson KM; Lee HC; Golden-Mason L; Rosen HR; Hahn YS
J Immunol; 2016 Mar; 196(5):2283-92. PubMed ID: 26826241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]